AI Article Synopsis
Article Abstract
The effect of diabetes on insulin receptor processing was assessed in rat hepatocytes, 2-4 weeks after the induction of diabetes with streptozotocin. Isolated hepatocytes from control and diabetic rats were labelled for 30 min with [35S]methionine in methionine-free medium and chased with complete medium for 1-3 hrs. Solubilized cell extracts were immunoprecipitated with a site-specific anti-insulin receptor antibody, proteins were separated by electrophoresis and labelling quantified following autoradiography. After 1 hr chase, only the insulin proreceptor was labelled in both groups. After 3 hrs, the ratio of labelled proreceptors to labelled insulin receptors was 0.57 +/- 0.063 in controls and 1.33 +/- 0.24 in hepatocytes from diabetic rats. Insulin added in vitro did not affect transit time. Delayed processing of the insulin proreceptor may reflect altered N-glycosylation and may also involve other glycoproteins.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1006/bbrc.1994.2519 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface.
Mol Biol Cell
November 2020
Department of Biosciences, Durham University, Durham DH1 3LE, United Kingdom.
Accumulation of unfolded proteins in the endoplasmic reticulum (ER) causes ER stress and activates a signaling network known as the unfolded protein response (UPR). Here we characterize how ER stress and the UPR inhibit insulin signaling. We find that ER stress inhibits insulin signaling by depleting the cell surface population of the insulin receptor.
View Article and Find Full Text PDFStructural Basis and Genotype-Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance.
Diabetes
October 2017
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
The insulin receptor () gene was analyzed in four patients with severe insulin resistance, revealing five novel mutations and a deletion that removed exon 2. A patient with Donohue syndrome (DS) had a novel p.V657F mutation in the second fibronectin type III domain (FnIII-2), which contains the α-β cleavage site and part of the insulin-binding site.
View Article and Find Full Text PDFA new highly efficient substrate-trapping mutant of protein tyrosine phosphatase 1B (PTP1B) reveals full autoactivation of the insulin receptor precursor.
J Biol Chem
June 2011
INSERM U1016, F-75014 Paris, France.
PTP1B is a protein tyrosine-phosphatase located on the cytosolic side of the endoplasmic reticulum that plays an important role in the regulation of the insulin receptor (IR). Replacement of the conserved Asp-181 by alanine is known to convert PTP1B into a substrate-trapping protein that binds to but cannot dephosphorylate its substrates. In this work, we have studied the effect of an additional mutation (Y46F) on the substrate-trapping efficiency of PTP1B-D181A.
View Article and Find Full Text PDFFounder effect in the Horn of Africa for an insulin receptor mutation that may impair receptor recycling.
Diabetologia
May 2011
University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital B289, Cambridge, CB2 0QR, UK.
Aims/hypothesis: Genetic insulin receptoropathies are a rare cause of severe insulin resistance. We identified the Ile119Met missense mutation in the insulin receptor INSR gene, previously reported in a Yemeni kindred, in four unrelated patients with Somali ancestry. We aimed to investigate a possible genetic founder effect, and to study the mechanism of loss of function of the mutant receptor.
View Article and Find Full Text PDFFunctional characterization of a novel insulin receptor mutation contributing to Rabson-Mendenhall syndrome.
Clin Endocrinol (Oxf)
January 2007
University of Cambridge Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK.
Objective/patients: Rabson-Mendenhall syndrome (RMS) is a rare, recessively inherited disorder of extreme insulin resistance due to mutations in the insulin receptor gene. We have identified a pair of siblings with RMS attributable to compound heterozygosity for two insulin receptor mutations, one previously unreported, and have characterized the novel receptor mutation functionally.
Measurements: Insulin receptor sequencing was performed to identify the mutations.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!